XML 55 R38.htm IDEA: XBRL DOCUMENT
v3.25.1

Research and Development Expenses (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Research and Development Expenses [Abstract] |
Schedule of Research and Development Expenses | Research and development expenses
|  | For the year ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | U.S. dollars in thousands |
Subcontractors and consultants |  | $ | 3,530 |  |  | $ | 4,794 |  |  | $ | 3,612 |
Share-based compensation |  |  | 193 |  |  |  | 575 |  |  |  | 570 |
Salaries and social benefits (*) |  |  | 1,975 |  |  |  | 1,905 |  |  |  | 1,405 |
|  | $ | 5,698 |  |  | $ | 7,274 |  |  | $ | 5,587 |

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentExpenseAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration